WV HB 4075

died on adjournment

Insurance must cover Bioidentical hormones as they do pharmaceutical one

West Virginia · 2026 Regular Session · lower

Quick answers

Did WV HB 4075 pass?

No. WV HB 4075 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-14): To House Finance

What is WV HB 4075 about?

WV HB 4075 is a bill in the 2026 Regular Session titled “Insurance must cover Bioidentical hormones as they do pharmaceutical one”.

Who sponsors WV HB 4075?

Crouse is the primary sponsor of WV HB 4075, joined by 2 cosponsors.

Introduced: 2026-01-14
Latest action: 2026-01-14 — To House Finance
Bill type: bill
Last updated: —

Subjects

Insurance

Committees

Not provided by source.

Action timeline

2026-01-14
Filed for introduction
filing
2026-01-14
To Finance then Judiciary
referral-committee
2026-01-14
Introduced in House
introduction
2026-01-14
To House Finance
referral-committee

Versions

Introduced VersionCompare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

https://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=4075&year=2026&sessiontype=RS&btype=bill

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:38:23.680216Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=WV&identifier=HB 4075. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.